Connor, Clark & Lunn Investment Management Ltd. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$969,239
+158.1%
25,682
+211.6%
0.01%
+150.0%
Q2 2023$375,506
-18.5%
8,242
-8.8%
0.00%
-33.3%
Q4 2022$460,871
-85.1%
9,042
-76.4%
0.00%
-81.2%
Q2 2021$3,090,000
-72.0%
38,382
-70.7%
0.02%
-74.2%
Q1 2021$11,051,000
-32.6%
131,031
-35.9%
0.06%
-36.1%
Q4 2020$16,390,000
+206.0%
204,262
+206.7%
0.10%
+169.4%
Q3 2020$5,356,000
-12.6%
66,606
-9.1%
0.04%
-14.3%
Q4 2019$6,127,000
-66.2%
73,275
-70.2%
0.04%
-58.8%
Q2 2018$18,128,000
-41.3%
245,500
-48.3%
0.10%
-45.5%
Q1 2018$30,905,000
+7.8%
475,175
+7.2%
0.19%
+12.0%
Q4 2017$28,660,000
-7.6%
443,375
-10.3%
0.17%
-10.2%
Q3 2017$31,014,000
+20.0%
494,250
+15.8%
0.19%
+9.4%
Q2 2017$25,843,000
-18.3%
426,875
-30.0%
0.17%
-18.3%
Q1 2017$31,618,000
+51.2%
609,675
+29.3%
0.21%
+45.5%
Q4 2016$20,907,000
+62.3%
471,525
+74.3%
0.14%
+58.9%
Q3 2016$12,879,000
+141.5%
270,575
+108.5%
0.09%
+119.5%
Q1 2016$5,332,000
+33.0%
129,800
+23.5%
0.04%
+20.6%
Q4 2015$4,010,000
+450.1%
105,100
+373.4%
0.03%
+466.7%
Q3 2015$729,000
-13.2%
22,200
+89.7%
0.01%
-14.3%
Q3 2014$840,000
-12.0%
11,700
-5.6%
0.01%0.0%
Q2 2014$955,00012,4000.01%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders